You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Olaratumab

Showing 1 - 25 of 26
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Soft Tissue Sarcoma Trial in Worldwide (Olaratumab, Pembrolizumab)

Active, not recruiting
  • Soft Tissue Sarcoma
  • Boston, Massachusetts
  • +5 more
Jul 19, 2022

Sarcoma, Soft Tissue Trial in Madrid (Olaratumab and Trabectedin)

Active, not recruiting
  • Sarcoma, Soft Tissue
  • Olaratumab and Trabectedin
  • Madrid, Spain
    GEIS
Apr 23, 2021

Tumor Trial in Japan (Olaratumab, Doxorubicin)

Completed
Has Results
  • Neoplasm
  • Chuo-Ku, Japan
  • +3 more
Feb 9, 2021

Soft Tissue Sarcoma Trial in Worldwide (Olaratumab)

Available
  • Soft Tissue Sarcoma
  • Olaratumab
  • Glendale, Arizona
  • +92 more
Aug 17, 2022

Soft Tissue Sarcoma Trial in Germany, Italy, United States (Olaratumab, Doxorubicin, Ifosfamide)

Completed
Has Results
  • Soft Tissue Sarcoma
  • Olaratumab
  • +3 more
  • Miami, Florida
  • +5 more
Aug 22, 2020

Advanced Soft Tissue Sarcoma Trial in Bad Saarow, Berlin, Dresden (Olaratumab, Dexrazoxane, Doxorubicin)

Terminated
  • Advanced Soft Tissue Sarcoma
  • Olaratumab
  • +2 more
  • Bad Saarow, Germany
  • +3 more
Jul 13, 2020

Soft Tissue Sarcoma Adult Trial in Lake Success, Portland, Seattle (Multiple drug microinjection, CIVO device)

Completed
  • Soft Tissue Sarcoma Adult
  • Multiple drug microinjection
  • CIVO device
  • Lake Success, New York
  • +2 more
Sep 22, 2021

Tumor Metastasis Trial in Japan, United States (Olaratumab, Doxorubicin, Vincristine)

Completed
Has Results
  • Neoplasm Metastasis
  • Olaratumab
  • +4 more
  • Phoenix, Arizona
  • +20 more
May 5, 2020

Sarcoma, Soft Tissue Trial in United States (Olaratumab, Doxorubicin)

Completed
Has Results
  • Sarcoma, Soft Tissue
  • Los Angeles, California
  • +5 more
Oct 31, 2019

Soft Tissue Sarcoma Trial in Worldwide (Olaratumab, Doxorubicin, Placebo)

Active, not recruiting
Has Results
  • Soft Tissue Sarcoma
  • Olaratumab
  • +2 more
  • Duarte, California
  • +117 more
Mar 22, 2022

Ovarian Tumors Trial in United States (Olaratumab, liposomal doxorubicin)

Completed
Has Results
  • Ovarian Neoplasms
  • Olaratumab
  • liposomal doxorubicin
  • Joliet, Illinois
  • +5 more
Sep 10, 2019

Leiomyosarcoma Trial (Trabectedin, Doxorubicin, Olaratumab)

Withdrawn
  • Leiomyosarcoma
  • (no location specified)
Mar 14, 2019

Soft Tissue Sarcoma Trial in Worldwide (Olaratumab, Doxorubicin, External Beam Radiotherapy)

Completed
Has Results
  • Soft Tissue Sarcoma
  • Olaratumab
  • +2 more
  • Los Angeles, California
  • +13 more
Jun 28, 2019

Prostate Cancer Trial in Worldwide (Olaratumab, Mitoxantrone, Prednisone)

Completed
Has Results
  • Prostate Cancer
  • Olaratumab
  • +2 more
  • Charleroi, Belgium
  • +39 more
Sep 5, 2019

Leiomyosarcoma, Liposarcoma, Soft Tissue Sarcoma Adult Trial in Taipei (Eribulin, Lenvatinib)

Active, not recruiting
  • Leiomyosarcoma
  • +3 more
  • Taipei, Taiwan
  • +1 more
Dec 27, 2022

Soft Tissue Sarcoma Trial in Switzerland (Nab-Paclitaxel, gemcitabine)

Terminated
  • Soft Tissue Sarcoma
  • Basel, Switzerland
  • +7 more
Sep 27, 2022

NSCLC Trial in Canada, United States (Olaratumab, Paclitaxel, Carboplatin)

Completed
Has Results
  • Non-Small Cell Lung Cancer
  • Olaratumab
  • +2 more
  • Birmingham, Alabama
  • +22 more
Dec 16, 2018

Cancer Target Therapy Efficacy

Active, not recruiting
  • Cancer
  • RNA sequencing
  • +5 more
  • Walnut, California
  • +6 more
Sep 13, 2021

Sensitivity to Doxorubicin/Doxil in Soft Tissue Sarcoma

Active, not recruiting
  • Soft Tissue Sarcoma
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Jan 25, 2023

Soft Tissue Sarcoma, Advanced Cancer, Metastatic Cancer Trial in France (Blood and tumor samples)

Recruiting
  • Soft Tissue Sarcoma
  • +2 more
  • Blood and tumor samples
  • Clermont-Ferrand, France
  • +9 more
Dec 8, 2021

Soft Tissue Sarcoma Adult, Advanced Cancer Trial in Beijing (Apatinib)

Withdrawn
  • Soft Tissue Sarcoma Adult
  • Advanced Cancer
  • Beijing, Beijing, China
  • +2 more
May 15, 2020

Progression-free Survival, Overall Survival, Toxicity Trial in Beijing (pegylated liposomal doxorubicin, pirarubicin)

Withdrawn
  • Progression-free Survival
  • +2 more
  • Beijing, China
    Peking University People's Hospital
May 15, 2020

Adult Glioblastoma Multiforme Trial in United States (olaratumab, ramucirumab)

Completed
Has Results
  • Adult Glioblastoma Multiforme
  • olaratumab
  • ramucirumab
  • Birmingham, Alabama
  • +10 more
Nov 30, 2017

Sarcoma, Soft Tissue Trial in United States (Olaratumab, doxorubicin)

Completed
Has Results
  • Sarcoma, Soft Tissue
  • Tucson, Arizona
  • +16 more
Mar 3, 2017

Gastrointestinal Stromal Tumor (GIST) Trial in Worldwide (Olaratumab)

Terminated
Has Results
  • Gastrointestinal Stromal Tumor (GIST)
  • Olaratumab
  • Chicago, Illinois
  • +12 more
Jan 27, 2017